NIMS Medical Genetics department in Hyderabad offers cutting-edge diagnostic and therapeutic services for rare genetic ...

Body odour is usually associated with adults, particularly those going through puberty, but it can also be a concern in infants.

Graselyn Jackie Straughter, 9, a Walker County 4-H member from Huntsville, earned Grand Champion Heifer and Champion Heifer Calf with BHSC GS Pandora 4M in the Charolais heifer division at the 2025 ...

pay a consent fee of EUR 0.90 per bond still outstanding after the upcoming bondholder meeting and the cancellation of the repurchased 2025 OCEANEs. Both proposals are subject to approval of the ...

Moderna Inc.’s stock fell 3% early Friday, after the biotech posted a wider-than-expected fourth-quarter loss and offered soft guidance for 2025, offsetting a revenue beat. Cambridge, Mass.-based ...

Reports fourth quarter revenues of $1.0 billion, GAAP net loss of $(1.1) billion and GAAP EPS of $(2.91); loss includes approximately $0.2 billion of non-cash charges related to manufacturing resizing ...

Government of India has provided tax relief on life-saving drugs and medicines used for rare diseases. As per the Ministry of Finance’s response in Rajya Sabha on February 11, 2025, basic customs duty ...

HC Wainwright reissued their buy rating on shares of Genfit (NASDAQ:GNFT – Free Report) in a report published on Friday,Benzinga reports. HC Wainwright currently has a $13.00 price target on the stock ...

In conjunction with the royalty financing deal with HealthCare Royalty (HCRx) announced on January 30, 2025, GENFIT will request the consent of the holders of 2025 OCEANEs and proposes: to repurchase ...

"Preserving Public Trust in U.S. Newborn Screening System," authored by NORD in partnership with a dozen rare disease patient advocacy organizations, explores the retention and se ...

ACLF clinical trials expected to initiate in 1Q253 clinical data readouts expected by year-end 2025 across the ACLF pipeline, including on-going UNVEIL-IT® Phase 2 trialData of on-going Phase 1b ...